NCT04758871View on ClinicalTrials.gov

Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 11, 2023

Study Completion Date

June 13, 2024

Conditions
Frozen Embryo TransferHormone Replacement TherapyDydrogesteroneInfertility, Female
Interventions
DRUG

Dydrogesterone 10 MG Oral Tablet

10 mg three times daily

DRUG

Micronized progesterone

2x 200 mg vaginal tablets two times daily

Trial Locations (1)

1090

Brussels IVF, Brussels

All Listed Sponsors
lead

CRG UZ Brussel

OTHER

NCT04758871 - Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles | Biotech Hunter | Biotech Hunter